Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Reexamination Certificate
2005-06-21
2005-06-21
Caputa, Anthony (Department: 1645)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
C424S009340, C424S093440, C424S165100, C424S184100, C424S185100, C424S190100, C424S234100, C424S237100, C435S007340, C435S068100, C435S069100, C435S069300, C435S070100, C435S071100, C524S023000, C530S388400, C530S403000, C536S023400, C536S023700, C930S290000
Reexamination Certificate
active
06908619
ABSTRACT:
The CAMP factor gene ofStreptococcus uberis(S. uberis) is described, as well as the recombinant production of CAMP factor therefrom. CAMP factors can be used in vaccine compositions for the prevention and treatment of bacterial infections.
REFERENCES:
patent: 0 626 452 (1994-11-01), None
patent: WO 96/41879 (1996-12-01), None
Herzog et al. DNA and Cell Biology 12(6):465-471, 1993.
Rudinger et al. “Peptide Hormones” Edit Ed by Parsons University Park Press, 1976.
Burgess et al J Cell Biol 111:2129-2138, 1990.
Levinson et al. Examination & Board Review Medical Microbiology & Immunology p. 292-293, 1974.
Podbielski Med Microbiol Immunol 183:239-256, 1994.
Williams Lett Appl Microbiol 12(1):23-8, 1991.
Sambrook et al. Molecular Cloning, A Laboratory Manual C SH 1989, 17 Expression of Cloned Genes inE coli, 1989.
George et al. Macromal Sequencing Synthesis Select Meth Appl Alan Liss Inc., 1988.
Bernheimer et al., “Nature and Mechanism of Action of the CAMP Protein of Group B Streptococci,”Infection and Immunity 23(3):838-844 (1979).
Christie et al., “A Note on a Lytic Phenomenon Shown by Group B Streptococci,”Aus. J. Exp. Bio. Med. Sci. 22:197-200 (1944).
Fehrenbach et al., “Interaction of Amphiphilic Bacterial Polypeptides With Artifical Membranes,”Bacterial Protein Tokins, pp. 317-324 (1984).
Rühlmann et al., “Complete Amino Acid Sequence of Protein B,”Fed. of Europ. Biochem. Soc. 235(1,2):262-266 (1988).
Schneewind et al., “Cloning and Expression of the CAMP Factor of Group B Streptococci inEscherichia coli,” Infection&Immunity 56(8):2174-2179 (1988).
Skalka et al., “Lethal Effect of CAMP-Factor and UBERIS-Factor-a New Finding About Diffusible Exosubstances ofStreptococcus agalactiaeandStreptococcus uberis,” Zentralbl. Bakteriol. Ser. A 249:190-194 (1981).
Sterzik et al., “Interaction of the Camp-Factor FromS.agalactiaeWith Artificial Membranes,”Bacterial Protein Toxins, pp. 195-196 (1984).
Sterzik et al., “Structure and Function of CAMP Factor ofStreptococcus agalactiae,” Zentralbl. Bakteriol. Mikrobiol. Hyg. Abt. 1 15:101-108 (1985).
Fehrenbach et al., “Role of CAMP-Factor (Protein B) for Virulence,” (Eds.)Bacterial Protein Toxins, Zbl. Bakt. Suppl. 17:351-357 (1988).
Figura et al., “Differentiation of Motile and Mesophilic Aeromonas Strains Into Species by Testing for a CAMP-Like Factor,”J. Clin. Microbiol. 25(7):1341-1342 (1987).
Fraser, Gordon, “Bacteriology: Haemolytic Activity of Corynebacterium,”Nature 189:246 (1961).
Frey et al., “Cloning and Expression of a Cohemolysin, the CAMP Factor ofActinobacillus pleuropneumoniae,” Infection&Immunity 57(7):2050-2056 (1989).
Jiang et al., Cloning, Sequencing and Expression of the CAMP Factor Gene ofStreptococcus uberis, 20:297-307 (1996).
Jürgens et al., “Purification and Characterization of Camp-Factor FromStreptococcus agalactiaeby Hydrophobic Interaction Chromatography and Chromatofocusing,”Journal of Chromatography, 348:363-370 (1985).
Jürgens et al., “Unspecific Binding of Group BStreptococcal cocytolysin(CAMP Factor) to Immunoglobulins and its Possible Roe in Pathogenicity,”J. Exp. Med. 165:720-732 (1987).
Kohler, W., “CAMP-Like Phenomens of Vibrios,”Zentralbl. Bakteriol. Mikrobiol. Hyg. Ser. A 270:35-40 (1988).
Rocourt et al., “Notes;Listeria welshimeriSp. Nov. andListerie seeligeriSp. Nov.,”Internationl. J. Syst. Bacteriol, 33(4):866-869 (1983).
Finch et al., “Further studies on the efficacy of a live vaccine against mastitis caused byStreptococcus uberis,” Vaccine 15(10):1138-1143, 1997.
Fontaine et al., “Immunisation of dairy cattle with recombinanttreptococcus uberisGapC or a chimeric CAMP antigen confers protection against heterologous bacterial challenge,” Vaccine 20:2278-2286, 2002.
Fontaine et al., “Immunisation of dairy cattle with recombinantStrptococcus uberisGapC or a chimeric CAMP antigen confers protection against heterologous bacterial challenge,” Vaccine 20:3047-3048, 2002.
Leigh et al., “Vaccination with the plasminogen activator fromStreptococcus uberisinduces an inhibitory response and protects against experimental infection in the dairy cow,” Vaccine 17:851-857, 1997.
Jiang Min
MacLachlan Philip Ronald
Potter Andrew A.
Caputa Anthony
Hines J.
Robins & Pasternak LLP
University of Saskatchewan
LandOfFree
Camp factor of streptococcus uberis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Camp factor of streptococcus uberis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Camp factor of streptococcus uberis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3463356